BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 12, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for Jan. 19, 2021

Jan. 19, 2021
New hires and promotions in the biopharma industry, including: Applied Molecular Transport, Antibiotic Research UK, Atea, Avrobio, Awakn, Beximco, Chiasma, Evolve, Evox, Frequency, Imago, Kite, Mersana, Neximmune, ONK, ONL, Receptor, RDIF, Sophia Genetics, Swanbio, Tarsus, Viridian, Xbiotech.
Read More

Appointments and advancements for Jan. 15, 2021

Jan. 15, 2021
New hires and promotions in the med-tech industry, including: Agilent, Pretel.
Read More

Appointments and advancements for Jan. 15, 2021

Jan. 15, 2021
New hires and promotions in the biopharma industry, including: Alligator, Kancera, Medipharm Labs, Nextcure, Novavax.
Read More

Appointments and advancements for Jan. 14, 2021

Jan. 14, 2021
New hires and promotions in the med-tech industry, including: Cognoa, Follica, H1, Vave Health.
Read More

Appointments and advancements for Jan. 14, 2021

Jan. 14, 2021
New hires and promotions in the biopharma industry, including: Amylyx, Lilly, Neonmind, ONK, Tryp, Ziopharm.
Read More

Appointments and advancements for Jan. 13, 2021

Jan. 13, 2021
New hires and promotions in the med-tech industry, including: Axol, Clinical Laserthermia, Healthtronics, Labminds, Mentice, Moon Surgical, Nanoview, Outset Medical, Rapid Medical, Rapid Micro Biosystems, Spineology, Vironix.
Read More

Appointments and advancements for Jan. 13, 2021

Jan. 13, 2021
New hires and promotions in the biopharma industry, including: Artios, Immunovant, Intelgenx, Tiziana.
Read More

Appointments and advancements for Jan. 12, 2021

Jan. 12, 2021
New hires and promotions in the med-tech industry, including: Conventus-Flower, Innovheart, Jumpcode Genomics, Molekule, Pliant Therapeutics, Rapid Medical, Regenesis Biomedical.
Read More

Appointments and advancements for Jan. 12, 2021

Jan. 12, 2021
New hires and promotions in the biopharma industry, including: Asklepios, Celyad, Lipigon, Moderna, Neuropathix, Pliant, Rejuveron, Sanofi.
Read More

Appointments and advancements for Jan. 11, 2021

Jan. 11, 2021
New hires and promotions in the med-tech industry, including: Cynosure, Cytosorbents, Deepcell, Seastar Medical, Voxneuro.
Read More
Previous 1 2 … 249 250 251 252 253 254 255 256 257 … 312 313 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 12, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • LINC01116 has prognostic value in lung cancer, study shows

    BioWorld Science
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing